...
首页> 外文期刊>Renal failure. >Thirty-month follow-up of coronary artery calcification in hemodialysis patients: different roles for inflammation and abnormal calcium-phosphorous metabolism?
【24h】

Thirty-month follow-up of coronary artery calcification in hemodialysis patients: different roles for inflammation and abnormal calcium-phosphorous metabolism?

机译:血液透析患者冠状动脉钙化的30个月随访:炎症和钙磷代谢异常的不同作用?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Cardiovascular disease is the leading cause of death in hemodialysis (HD) patients. Coronary artery calcification (CAC) is considered a marker of atherosclerosis and coronary artery disease (CAD). The CAC progression and factors that influence it were evaluated during a 30-month period. METHODS: Forty HD patients without a history of CAD were enrolled into the study. CAC score was assessed with conventional CT repeated every six months. The circulating factors of phosphorous, calcium, calcium-phosphorous product, intact parathyroid hormone, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, lipoprotein-alpha, albumin, high sensitivity C-reactive protein, and fibrinogen were measured monthly. Hypertension and calcium intake during the study period were taken into account as well. RESULTS: At baseline, CAC score was correlated with age and duration of HD therapy. From all evaluated factors, CAC initiation was influenced only by older age and C-reactive protein. CAC, when it was started, was aggravated continuously and was influenced only by elevated serum phosphorous and calcium-phosphorous product. Hypertension, lipid profile, and calcium intake did not affect CAC initiation or progression. CONCLUSIONS: Once CAC progression starts, it is an uninterrupted process. The roles of inflammation and abnormal calcium-phosphorous metabolism in CAC differ. Inflammation is the major factor that contributes in CAC initiation. Elevated serum phosphorous and calcium-phosphorous product accelerates CAC progression.
机译:背景:心血管疾病是血液透析(HD)患者死亡的主要原因。冠状动脉钙化(CAC)被认为是动脉粥样硬化和冠状动脉疾病(CAD)的标志。在30个月内评估了CAC进展和影响其的因素。方法:40例无CAD史的HD患者被纳入研究。每六个月重复一次常规CT评估CAC评分。磷,钙,钙磷产物,完整的甲状旁腺激素,总胆固醇,低密度脂蛋白胆固醇,高密度脂蛋白胆固醇,甘油三酸酯,脂蛋白-α,白蛋白,高敏C反应蛋白和纤维蛋白原的循环因子是每月测量一次。还考虑了研究期间的高血压和钙摄入量。结果:在基线时,CAC评分与HD治疗的年龄和持续时间相关。从所有评估的因素来看,CAC的启动仅受年龄和C反应蛋白的影响。开始时,CAC会不断加重,仅受血清磷和钙磷产物升高的影响。高血压,脂质状况和钙摄入量不影响CAC的开始或进展。结论:一旦开始CAC进展,这是一个不间断的过程。 CAC中炎症和钙磷代谢异常的作用不同。炎症是导致CAC启动的主要因素。血清磷和钙磷产物升高会加速CAC进程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号